You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 6, 2016

IP Lunch Talk: Tilleke & Gibbins and NIA to Hold Discussion on Healthcare Business

Subscribe to Updates
Tilleke & Gibbins and National Innovation Agency

The key drivers of healthcare product investment are the effective protection of intellectual property rights and compliance with the law. Protection of IP rights and obtaining market authorization are challenges faced by every company operating in the healthcare industry. To discuss these issues and more, Dr. Atthachai Homhuan, regulatory affairs manager at Tilleke & Gibbins, will present on “Intellectual Property and Regulatory Perspectives of Thailand’s Healthcare Business” at an IP Lunch Talk held by Tilleke & Gibbins and the National Innovation Agency. In particular, Atthachai will discuss the following issues:

  • IP rights and dealing with local distributors
  • Healthcare legislation and regulation in Thailand and ASEAN harmonization
  • Recent and upcoming changes to healthcare-related IP and laws/regulations in Thailand

This seminar will be held at Tilleke & Gibbins’ Bangkok office on May 26 from 11.30 a.m. to 1.30 p.m. Atthachai’s presentation will be followed by a Q&A session. If you would like to learn more about this event, please contact Pinta P. Macdougall at [email protected].

RELATED PROFESSIONAL

Industries

Life Sciences

Practices

Intellectual Property

Regulatory Affairs

Location

RELATED INSIGHTS​ 

October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
Read More
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
Read More
September 4, 2012
On September 21, 2012, Tilleke & Gibbins, together with the National Innovation Agency, will host a Thai-language seminar on “Medical Devices: Opportunities & Regulations.” The seminar with consist of three presentations, one of which will be conducted by Rarana Phanudulkitti, a consultant at Tilleke & Gibbins. With her expertise in regulatory affairs, Rarana will deal specifically with registering medical devices in Thailand, with an emphasis on best practices for companies in ensuring a smooth registration process.
Read More